BNTC
Benitec Biopharma
$8.80
+$0.12 (+1.38%)Oct 28, 2026
Key metrics
The numbers that frame BNTC today
- Market cap
- $306.97M
- ROIC
- 7,762.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $7.89
- 52wk High
- $16.68
Growth
Revenue and earnings trend for BNTC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BNTC
Is Benitec Biopharma a good buy?
No. Benitec Biopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Benitec Biopharma is selling at a very high price.
What is the market capitalization of BNTC?
Benitec Biopharma's market capitalization is $306.97M.
What is the 52-week high for BNTC stock?
The 52-week high for Benitec Biopharma is $16.68. The current close of $8.80 is 47.2% below that high.
What is the 52-week low for BNTC stock?
The 52-week low for Benitec Biopharma is $7.89. The current close of $8.80 is 11.6% above that low.
Does BNTC stock pay dividends?
Benitec Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BNTC?
Benitec Biopharma's Debt / Equity ratio is 0.